Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Peptide Anticoagulant Drugs Companies

Peptide drugs and anticoagulant drugs represent two distinct categories within the pharmaceutical industry. Peptide drugs are medications composed of peptides, which are short chains of amino acids. These drugs may have a wide range of therapeutic applications, from hormones and antibiotics to cancer treatments. Anticoagulant drugs, on the other hand, are medications that prevent the formation of blood clots and are commonly used to treat or prevent conditions such as deep vein thrombosis and atrial fibrillation.

peptide and anticoagulant drugs market

Latest Peptide And Anticoagulant Drugs Companies Updates:

Amylin Pharmaceuticals, Inc.: Received FDA approval for Pramlintide (Symlin®), a synthetic peptide analog of amylin, for use in managing Type 1 diabetes in adults in November 2023.

Boehringer Ingelheim: Announced the expansion of its clinical trial program for BI 782571, a novel oral Factor XIa inhibitor as a potential alternative to warfarin, in December 2023.

Roche Holding AG: Received FDA breakthrough therapy designation for RO7380710, a bispecific peptide-drug conjugate targeting IL-17A and IL-17F for treating psoriasis and other inflammatory diseases, in January 2024.

Hsieh's Biopharma Co., Ltd.: Launched a new manufacturing facility in China in February 2024 dedicated to producing peptide drugs, aiming to expand their production capacity and global reach.

PepGen, Inc.: Collaborated with a leading academic institution in January 2024 to develop AI-powered platforms for accelerating peptide drug discovery and optimization.

List of Peptide And Anticoagulant Drugs Key companies in the market:

Abbott Laboratories (U.S.)

Cadila Pharmaceuticals (India)

Sanofi S.A. (France)

Eli Lilly and Company (U.S.)

Cipla Limited (India)

Biocon Limited (India)

Intas Pharmaceuticals Ltd. (India)

Lupin Limited (India)

Emcure Pharmaceuticals Ltd. (India)

Peptide Anticoagulant Drugs Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.